Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.
Vous n'êtes pas connecté
MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.
Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.
HIG is well-poised for growth on the back of strong contribution from its Commercial Lines and Group Benefits businesses. A strong financial position...
Investors are increasingly optimistic about LH due to its focus on high-growth areas and strategic partnerships.
WASHINGTON, USA – The Office of Strategic Capital (OSC) released its Fiscal Year 2025 (FY25) Investment Strategy, which details how OSC will...
CNO remains well-poised for growth on a diversified product portfolio, new product launches, technology investments and prudent capital deployment...
[Lagos, Nigeria – January 06, 2025] – Guaranty Trust Holding Company Plc (“GTCO Plc” or the “Group”) (NGX: GTCO) is pleased to...
Revenue declines and intense competition pose significant challenges to WOLF's growth despite its expansion efforts and strong capital structure.
NDAQ is set to grow on the back of its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by...
Neiman Marcus and Bergdorf Goodman join Saks Global portfolio NEW YORK--(BUSINESS WIRE)--Saks Global, a leading luxury retail and real estate...
BASFY's divestment to LDC supports its strategic portfolio optimization and will help it focus on its core businesses in Nutrition & Health.